Cyberpunk 2077 is getting a big new 2.5 update that, among other features, brings cross-platform mod support to consoles and content inspired by the new season of the Cyberpunk: Edgerunners anime on Netflix. There's a lot to unpack in the full patch notes.

The Edgerunners-specific content includes a new side quest, a gear set based on the character Weak Kingsley, and a new radio station that plays Cyberpunk: Edgerunners music.

Even if you haven't seen the show, the update also adds a Double Trouble perk option that allows dual-wielding of pistols and revolvers, plus a Richard Night-guided tour of the city side quest, and access to a …

Read the full story at The Verge.

On Tuesday, US District Judge Zachary Bluestone dismissed the lawsuit Ann Altman filed last year alleging that her brother, OpenAI CEO Sam Altman, had sexually abused her throughout her childhood. As reported earlier by The Guardian, the judge wrote that over the past year, Ann had failed to appear for an independent medical examination or meet other deadlines despite warnings that it would result in the case being dismissed.

When the case was filed last year, a statement shared by Sam Altman, his mother, and his brothers said, "Annie has made deeply hurtful and entirely untrue claims about our family, and especially Sam… All of these claim …

Read the full story at The Verge.

Trying to pull up information for certain peptides on TikTok is now returning a "no results found" page when searching for terms like semaglutide, BPC-157, retratutide, and others. That hasn't entirely erased visibility on TikTok for peptides, which are combinations of amino acids that include substances like insulin and GLP-1. The problem is peptides also include unregulated, unapproved substances that proponents like RFK Jr. say can assist with everything from weight loss to wound healing, despite a lack of clinical data supporting such claims.

As a result, on social media platforms like TikTok, an army of influencer proponents are happy …

Read the full story at The Verge.